Polymorphisms of the CYR61 gene in patients with acute myeloid leukemia in a Han Chinese population

Medicine
Chang-Chun NiuPu Liao

Abstract

It was demonstrated in previous studies that cysteine-rich angiogenic inducer 61 (Cyr61) plays vital roles in hematological disorders, and we have already reported that the Cyr61 protein is a tumor promoter in acute myeloid leukemia (AML). Here, we investigated the association between CYR61 gene polymorphisms and susceptibility to AML.We genotyped 2 single-nucleotide polymorphisms (rs2297141 and rs6576776) in the region of the CYR61 gene by improved multiplex ligase detection reaction genotyping assays in a total of 275 samples, including samples from 137 AML patients and 138 healthy controls. Chi-squared tests and logistic regression analysis were performed to compare the different distributions of the genotypes and alleles between patients and healthy controls.The rs2297141 A allele was associated with lower risk of AML compared with the G allele (odds ratio [OR] = 0.704, 95% confidence interval [CI] = 0.503-0.985, P = .04) in both the dominant (OR = 0.447, 95% CI = 0.22-0.909, P = .025, AA vs GG) and recessive inheritance models (OR = 0.419, 95% CI = 0.23-0.763, P = .004, AA vs GA + GG). Although the distribution of the rs6576776 alleles was not different between patients with AML and normal controls, the CC genotype signifi...Continue Reading

References

Oct 10, 2012·Prostate Cancer and Prostatic Diseases·L TaoC Yin
May 2, 2014·Thyroid : Official Journal of the American Thyroid Association·Tereza PlanckMikael Lantz
Aug 20, 2014·Pediatric Cardiology·Andreas PerrotCemil Ozcelik
Sep 5, 2014·Cancer Cell International·Chang-Chun NiuWei-Ke Si
Jun 1, 2015·Journal of Cell Communication and Signaling·J E WellsUrsula R Kees
Oct 17, 2015·Annual Review of Medicine·Krishna V Komanduri, Ross L Levine
Oct 27, 2015·International Journal of Molecular Medicine·Jun LiWen G Jiang
Dec 17, 2015·Methods in Molecular Biology·Victoria ShawWilliam Greenhalf
Jun 9, 2016·The New England Journal of Medicine·Elli PapaemmanuilPeter J Campbell
Oct 26, 2016·Oncology Reports·Jun ChenXiangdong Chen
Nov 28, 2016·Neoplasia : an International Journal for Oncology Research·Makoto SanoBrian C Lewis
Mar 16, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lars BullingerHartmut Döhner
Mar 23, 2017·Experimental Cell Research·Lothar SeefriedRegina Ebert
Jul 5, 2017·The International Journal of Biochemistry & Cell Biology·Orit Shaul
Jan 14, 2018·Trends in Genetics : TIG·Kirstyn T Carey, Vihandha O Wickramasinghe

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
RNA-seq

Software Mentioned

Haploview
Comprehensive Perl Archive Network
PERL script
UALCAN

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.